v3.22.4
ACQUISITION-RELATED CHARGES (GAINS), IMPAIRMENT AND OTHER - MyoScience (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Business Acquisition [Line Items]      
Changes in contingent consideration $ (29,476) $ (989) $ 5,204
Myoscience Acquisition      
Business Acquisition [Line Items]      
Changes in contingent consideration $ 11,200 2,200 5,200
Acquisition related fees   $ 700 $ 200